Adial Pharmaceuticals, Inc. Liquidation Value Calculator
Adial Pharmaceuticals, Inc.
Current Price: N/A
Loading calculator data...
Advanced: All 102 XBRL Tags
Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.
Balance Sheet
| Tag | Value | Unit | ||
|---|---|---|---|---|
| accounts_payable | ||||
| Accounts Payable Current total AccountsPayableCurrent |
$655,207 | USD | ||
| cash | ||||
| Cash And Cash Equivalents At Carrying Value total CashAndCashEquivalentsAtCarryingValue |
$5.88M | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents total CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
$5.88M | USD | ||
| current_liabilities | ||||
| Accrued Liabilities Current total AccruedLiabilitiesCurrent |
$741,702 | USD | ||
| Other Accrued Liabilities Current total OtherAccruedLiabilitiesCurrent |
$77,495 | USD | ||
| liabilities_current | ||||
| Liabilities Current total LiabilitiesCurrent |
$1.40M | USD | ||
| liabilities_total | ||||
| Liabilities total | $1.40M | USD | ||
| long_term_investments | ||||
| Equity Method Investments total EquityMethodInvestments |
$489,700 | USD | ||
| Investments total | $1.73M | USD | ||
| shares_outstanding | ||||
| Common Stock Shares Outstanding total CommonStockSharesOutstanding |
1.1M | shares | ||
Unmapped Tags (90)
| Additional Paid In Capital AdditionalPaidInCapital | $95.25M | USD | ||
| Amortization Of Intangible Assets AmortizationOfIntangibleAssets | $565 | USD | ||
| Assets Assets | $6.67M | USD | ||
| Assets Current AssetsCurrent | $6.18M | USD | ||
| Cash FDIC Insured Amount CashFDICInsuredAmount | $17,000 | USD | ||
| Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Common Stock Shares Authorized CommonStockSharesAuthorized | $100.00M | shares | ||
| Common Stock Shares Issued CommonStockSharesIssued | $1.11M | shares | ||
| Common Stock Value CommonStockValue | $1,111 | USD | ||
| Deferred Tax Assets Gross DeferredTaxAssetsGross | $125,000 | USD | ||
| Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards | $14.99M | USD | ||
| Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance | $16.75M | USD | ||
| Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets | $530 | USD | ||
| Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill | $2,784 | USD | ||
| Investment Income Interest InvestmentIncomeInterest | $149,567 | USD | ||
| Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity | $6.67M | USD | ||
| Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Preferred Stock Shares Authorized PreferredStockSharesAuthorized | $5.00M | shares | ||
| Preferred Stock Shares Outstanding PreferredStockSharesOutstanding | $0 | shares | ||
| Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit | $-89.97M | USD | ||
| Stockholders Equity StockholdersEquity | $5.28M | USD | ||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | $344,500 | USD | ||
| Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense | $676,200 | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | $2.13M | USD | ||
| Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities | $125,000 | USD | ||
| Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | $575,700 | USD | ||
| Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities | $405,077 | USD | ||
| Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities | $100,296 | USD | ||
| Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties | $48,272 | USD | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | $-8,572 | USD | ||
| Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities | $8.47M | USD | ||
| Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities | $150,000 | USD | ||
| Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities | $-6.49M | USD | ||
| Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts | $3.00M | USD | ||
| Proceeds From Customers ProceedsFromCustomers | $93,044 | USD | ||
| Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock | $3.66M | USD | ||
| Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity | $8.50M | USD | ||
| Proceeds From Warrant Exercises ProceedsFromWarrantExercises | $4.81M | USD | ||
| Share Based Compensation ShareBasedCompensation | $676,200 | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue | $48 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice | $17 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | $1 | pure | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | $0 | pure | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | $1,242 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | $19,120 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | $17 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | $0 | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | $47,220 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | $151 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | $19,661 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | $331 | USD/shares | ||
| Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | $257 | USD/shares | ||
| Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | $17 | USD/shares | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | $1.29M | shares | ||
| Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense | $4.46M | USD | ||
| Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | $157,520 | USD | ||
| Earnings Per Share Basic EarningsPerShareBasic | $-12 | USD/shares | ||
| Earnings Per Share Diluted EarningsPerShareDiluted | $-12 | USD/shares | ||
| Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | $0 | pure | ||
| Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | $-0 | pure | ||
| Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | $0 | pure | ||
| General And Administrative Expense GeneralAndAdministrativeExpense | $5.18M | USD | ||
| Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | $-7.98M | USD | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | $-7.98M | USD | ||
| Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments | $-492,130 | USD | ||
| Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | $1.26M | USD | ||
| Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | $-1.68M | USD | ||
| Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments | $230 | USD | ||
| Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes | $-15,665 | USD | ||
| Net Income Loss NetIncomeLoss | $-7.98M | USD | ||
| Nonoperating Income Expense NonoperatingIncomeExpense | $-177,709 | USD | ||
| Operating Expenses OperatingExpenses | $7.80M | USD | ||
| Operating Income Loss OperatingIncomeLoss | $-7.80M | USD | ||
| Other General Expense OtherGeneralExpense | $36,048 | USD | ||
| Other Nonoperating Income Expense OtherNonoperatingIncomeExpense | $164,854 | USD | ||
| Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent | $299,666 | USD | ||
| Research And Development Expense ResearchAndDevelopmentExpense | $2.62M | USD | ||
| Royalty Expense RoyaltyExpense | $40,000 | USD | ||
| Number Of Operating Segments NumberOfOperatingSegments | $1 | Segment | ||
| Number Of Reportable Segments NumberOfReportableSegments | $1 | Segment | ||
| Other Income OtherIncome | $150,000 | USD | ||
| Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction | $4.90M | USD | ||
| Stock Issued1 StockIssued1 | $36,050 | USD | ||
| Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices | $367,750 | USD | ||
| Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues | $3.66M | USD | ||
| Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised | $4.81M | USD | ||
| Warrants And Rights Outstanding WarrantsAndRightsOutstanding | $300,000 | USD | ||
| Workers Compensation Liability Current WorkersCompensationLiabilityCurrent | $660,307 | USD | ||
| CashUninsuredAmount CashUninsuredAmount | $5.60M | USD | ||
| RecoveryOfDirectCosts RecoveryOfDirectCosts | $138,000 | USD |
Showing balance sheet tags only. Liquidation analysis uses balance sheet data.